|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 Resident in Thoracic and Cardiovascular Surgery, Veterans Administration Hospital, Oteen
2 Resident in Surgery, Duke University, Durham, NC; now in private practice, Asheville, NC
3 Chief, Surgical Service, Veterans Administration Hospital, Oteen
Two fatalities following percutaneous lung biopsy are reported. Cause of death was sudden massive endobronchial hemorrhage. The use of a cutting type (Vim-Silverman or Franklin-Silverman) needle is condemned on the basis of (a) review of the other 11 fatalities reported in the literature and (b) morbidity, mortality, and diagnostic yield figures from reported series.
This article has been cited by other articles:
![]() |
R. D. Suh, J. G. Goldin, A. B. Wallace, R. E. Sheehan, S. B. Heinze, B. J. Gitlitz, and R. A. Figlin Metastatic Renal Cell Carcinoma: CT-guided Immunotherapy as a Technically Feasible and Safe Approach to Delivery of Gene Therapy for Treatment Radiology, May 1, 2004; 231(2): 359 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Manhire, M Charig, C Clelland, F Gleeson, R Miller, H Moss, K Pointon, C Richardson, and E Sawicka Guidelines for radiologically guided lung biopsy Thorax, November 1, 2003; 58(11): 920 - 936. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |